Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular comfort trial of lipid tear supplements in contact lens wearers
ACTRN12613001323718Phase 3Completed
- Sponsor
- Brien Holden Vision Institute
- Start
- May 2013
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Systane Balance and TearsAgain in Contact lens discomfort (CLD) and dry eye syndrome (DED) (4 arms), sponsored by Brien Holden Vision Institute. Primary endpoint: Ocular comfort index score. Started May 2013; status: completed.
02
Drugs
Systane BalanceTearsAgain
03
Conditions
Contact lens discomfort (CLD)dry eye syndrome (DED)
Beyond the preview
Go deeper on ACTRN12613001323718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001323718.